EZZ Life Science Holdings (ASX:EZZ) Equity-to-Asset : 0.75 (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is EZZ Life Science Holdings Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. EZZ Life Science Holdings's Total Stockholders Equity for the quarter that ended in Dec. 2023 was A$15.30 Mil. EZZ Life Science Holdings's Total Assets for the quarter that ended in Dec. 2023 was A$20.30 Mil. Therefore, EZZ Life Science Holdings's Equity to Asset Ratio for the quarter that ended in Dec. 2023 was 0.75.

The historical rank and industry rank for EZZ Life Science Holdings's Equity-to-Asset or its related term are showing as below:

ASX:EZZ' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.75 Med: 0.83 Max: 0.85
Current: 0.75

During the past 4 years, the highest Equity to Asset Ratio of EZZ Life Science Holdings was 0.85. The lowest was 0.75. And the median was 0.83.

ASX:EZZ's Equity-to-Asset is ranked better than
59.23% of 1555 companies
in the Biotechnology industry
Industry Median: 0.67 vs ASX:EZZ: 0.75

EZZ Life Science Holdings Equity-to-Asset Historical Data

The historical data trend for EZZ Life Science Holdings's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

EZZ Life Science Holdings Equity-to-Asset Chart

EZZ Life Science Holdings Annual Data

Trend

Jun20

Jun21

Jun22

Jun23

Equity-to-Asset

0.68

0.84

0.80

0.83

EZZ Life Science Holdings Semi-Annual Data
	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Equity-to-Asset	Get a 7-Day Free Trial			0.85	0.80	0.84	0.83	0.75

Competitive Comparison of EZZ Life Science Holdings's Equity-to-Asset

For the Biotechnology subindustry, EZZ Life Science Holdings's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

EZZ Life Science Holdings's Equity-to-Asset Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, EZZ Life Science Holdings's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where EZZ Life Science Holdings's Equity-to-Asset falls into.

EZZ Life Science Holdings Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

EZZ Life Science Holdings's Equity to Asset Ratio for the fiscal year that ended in Jun. 2023 is calculated as

Equity to Asset (A: Jun. 2023 )	=	Total Stockholders Equity	/	Total Assets
	=	14.582	/	17.641
	=	0.83

EZZ Life Science Holdings's Equity to Asset Ratio for the quarter that ended in Dec. 2023 is calculated as

Equity to Asset (Q: Dec. 2023 )	=	Total Stockholders Equity	/	Total Assets
	=	15.298	/	20.297
	=	0.75

EZZ Life Science Holdings (ASX:EZZ) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.

EZZ Life Science Holdings Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of EZZ Life Science Holdings's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

EZZ Life Science Holdings (ASX:EZZ) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » EZZ Life Science Holdings Ltd (ASX:EZZ) » Definitions » Equity-to-Asset

Comparable Companies

Traded in Other Exchanges

N/A

Address

104 Derby Street, Silverwater, NSW, AUS, 2128

Website

https://www.ezzlife.com.au

EZZ Life Science Holdings Ltd is a genomic life science company with a mission to improve quality of life and human health. EZZ has a focus on genomic research and development to address four key human health challenges: genetic longevity, human papillomavirus (HPV), helicobacter pylori, and weight management. The company is engaged in formulation, production, marketing and sale of the EZZ branded health and wellbeing products to retailers and consumers domestically and internationally, and wholesale distribution of the EAORON branded skin care products to retailers in Australia and New Zealand.

EZZ Life Science Holdings (ASX:EZZ) Headlines

No Headlines